StartsideMEHCQ • OTCMKTS
add
23andMe Holding Co.
Forrige sluttkurs
1,17 $
Dagsintervall
1,07 $ - 1,18 $
Årsintervall
0,48 $ - 12,76 $
Markedsverdi
30,85 mill. USD
Gjennomsnittlig volum
8,09 mill.
P/E-tall
-
Utbytte
-
Hovedbørs
OTCMKTS
I nyhetene
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(USD) | des. 2024info | Endring år til år |
---|---|---|
Omsetning | 60,26 mill. | 34,67 % |
Driftskostnader | 65,06 mill. | −22,18 % |
Nettoomsetning | −53,04 mill. | 80,92 % |
Netto resultatmargin | −88,01 | 85,83 % |
Fortjeneste per aksje | — | — |
EBITDA | −21,80 mill. | 62,70 % |
Faktisk avgiftssats | — | — |
Balanseregnskap
Totale aktiva
Totale passiva
(USD) | des. 2024info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 79,35 mill. | −67,27 % |
Totale aktiva | 277,42 mill. | −54,39 % |
Totale passiva | 214,70 mill. | −7,06 % |
Total egenkapital | 62,72 mill. | — |
Utestående aksjer | 26,83 mill. | — |
P/B-forhold | 0,50 | — |
Avkastning på aktiva | −21,15 % | — |
Avkastning på kapital | −42,49 % | — |
Kontantstrøm
Netto kontantstrøm
(USD) | des. 2024info | Endring år til år |
---|---|---|
Nettoomsetning | −53,04 mill. | 80,92 % |
Kontantstrøm fra drift | −44,65 mill. | −270,23 % |
Kontanter fra investering | 887,00k | 144,09 % |
Kontanter fra finansiering | −19,00k | −118,10 % |
Netto kontantstrøm | −43,79 mill. | −213,47 % |
Fri kontantstrøm | −20,18 mill. | −469,10 % |
Om
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Grunnlagt
apr. 2006
Hovedkvarter
Nettsted
Ansatte
571